ATTUNE RX
Live / Applied — Statement of use — registration review complete (as of 26 Oct 2026)
What this means for you
Not registered yet, but its 26 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99517322
- Mark type
- Word mark
- Filed
- 26 Nov 2025
- Published for opposition
- 07 Jul 2026
- Attorney of record
- ELIAS HANTULA
Goods and services
- Class 005 — Pharmaceuticals: Dietary supplements; Dietary supplements for human consumption; Natural dietary supplements; Dietary and nutritional supplements for headache, nausea and fatigue associated with hangover
Owner
- Attune Rx Pharmaceutical CO., LTD., New Taipei City, TW
- Attune Rx Pharmaceutical CO., LTD., New Taipei City, TW
Prosecution history
- 26 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Oct 2026 — USE AMENDMENT FILED
- 13 Oct 2026 — TEAS STATEMENT OF USE RECEIVED
- 01 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jul 2026 — PUBLISHED FOR OPPOSITION
- 01 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION E-MAILED